Loading...

Biotin anti-mouse NK-1.1 Antibody

Pricing & Availability
Clone
PK136 (See other available formats)
Regulatory Status
RUO
Other Names
NKR-P1C, NKR-P1B, Ly-55, CD161, CD161b, CD161c
Isotype
Mouse IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
PK136_Biotin_1_110210
C57BL/6 mouse splenocytes were stained with CD49b (DX5) APC and biotinylated NK1.1 (clone PK136) (top) or mouse IgG2a isotype control, followed by Sav-PE (bottom).
  • PK136_Biotin_1_110210
    C57BL/6 mouse splenocytes were stained with CD49b (DX5) APC and biotinylated NK1.1 (clone PK136) (top) or mouse IgG2a isotype control, followed by Sav-PE (bottom).
  • PK136_Biotin_2_110210
Compare all formats
Cat # Size Price Quantity Check Availability Save
108703 50 µg 38€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
108704 500 µg 106€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-γ production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
NK-1+ cells from mouse spleen and bone marrow
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1,2, complement-dependent cytotoxicity3, in vivo depletion4,5,9,10, mediation of in vitro redirected lysis6, blocking of NK cell function7, induction of proliferation8, immunohistochemical staining of frozen sections11, immunofluorescence microscopy11, and spatial biology (IBEX)16,17. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 108712).

Application References
  1. Carlyle JR, et al. 1999. J. Immunol. 162:5917. (IP)
  2. Sentman CL, et al. 1989. Hybridoma 8:605. (IP)
  3. Koo GC, et al. 1984. Hybridoma 3:301. (Cyt)
  4. Sentman CL, et al. 1989. J. Immunol. 142:1847. (Deplete)
  5. Koo GC, et al. 1986. J. Immunol. 137:3742. (Deplete)
  6. Karlhofer FM, et al. 1991. J. Immunol. 146:3662.
  7. Kung SK, et al. 1999. J. Immunol. 162:5876. (Block)
  8. Reichlin A, et al. 1998. Immunol. Cell Biol. 76:143.
  9. Drobyski W, et al. 1996. Blood 87:5355. (Deplete)
  10. Andoniou CE, et al. 2005. Nat. Immunol. 6:1011. (Deplete)
  11. Kanwar JR, et al. 2001. J. Natl. Cancer Inst. 93:1541. (IHC, IF)
  12. Kroemer A, et al. 2008. J. Immunol. 180:7818. PubMed
  13. Kim JY, et al. 2009. Exp Mol Med. 30:288. PubMed
  14. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  15. Lee H, et al. 2014. Invest Ophthalmol Vis Sci. 55:2885. PubMed
  16. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  17. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Hu J, et al. 2019. Am J Transl Res. 3.043055556. PubMed
  2. Song R, et al. 2022. Immunology. 165:274. PubMed
  3. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  4. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  5. Tomiaki C, et al. 2022. Front Immunol. 13:1014462. PubMed
  6. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  7. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  8. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  9. Tanaka T, et al. 2023. Nat Immunol. 24:439. PubMed
  10. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  11. Li S, et al. 2022. Elife. 11:. PubMed
  12. Obi AT, et al. 2023. Sci Rep. 13:3253. PubMed
  13. Florentin J, et al. 2022. Front Immunol. 13:882484. PubMed
  14. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  15. Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed
  16. Davis FM, et al. 2020. J Immunol. 2503:204. PubMed
  17. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  18. Garza-Rodea A, et al. 2011. PLoS One. 6:e14493. PubMed
  19. Wang L, et al. 2019. Cell Rep. 29:1848. PubMed
  20. Giambra V et al. 2018. Cell stem cell. 23(5):714-726 . PubMed
  21. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  22. Matson CA, et al. 2020. Proc Natl Acad Sci U S A. 117:14342. PubMed
  23. Krueger PD, et al. 2021. Immunity. 54(4):687-701.e4. PubMed
  24. Pokrovskii M, et al. 2020. EMBO J. 39:e104159. PubMed
  25. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  26. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  27. Xu X, et al. 2020. J Cell Biol. 219:00:00. PubMed
  28. Wang T, et al. 2020. Blood Sci. 2:79. PubMed
  29. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
  30. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  31. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  32. Kimball A, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1102. PubMed
  33. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  34. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  35. He J, et al. 2020. Cell Reports. 29(9):2718-2730.e6.. PubMed
  36. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  37. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  38. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  39. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  40. Shen Z, et al. 2021. iScience. 24:103014. PubMed
  41. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  42. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  43. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  44. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  45. Yao M, et al. 2020. Cell. 180(3):502-520. PubMed
  46. Hutter K, et al. 2020. FEBS J. . PubMed
  47. Dong S, et al. 2021. Nature. 591:117. PubMed
  48. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  49. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  50. Aschman T, et al. 2021. Int J Mol Sci. 22:. PubMed
  51. Zeng Z, et al. 2022. Oncogene. :. PubMed
  52. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  53. Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
  54. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  55. Georgoudaki A, et al. 2016. Cell Rep. 15: 2000-2011. PubMed
  56. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  57. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  58. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  59. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  60. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  61. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  62. Frohner IE, et al. 2020. Cell Rep. 30:3171. PubMed
  63. Bagadia P, et al. 2019. Nat Immunol. 20:1174. PubMed
  64. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  65. Zhu Z, et al. 2013. Proc Natl Acad Sci U S A. 110:1282. PubMed
  66. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  67. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  68. Anderson DA, et al. 2022. J Exp Med. 219:. PubMed
  69. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  70. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  71. O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed
  72. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  73. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  74. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  75. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  76. Becklund B, et al. 2016. Sci Rep. 6:30842. PubMed
  77. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
RRID
AB_313390 (BioLegend Cat. No. 108703)
AB_313390 (BioLegend Cat. No. 108704)

Antigen Details

Structure
NKR-P1 gene family
Distribution

NK and NK-T cells in the NK1.1 mouse strains (C57BL, FVB/N, NZB)

Function
NK cell activation, IFN-γ production, cytotoxic granule release
Cell Type
NK cells, NKT cells
Biology Area
Immunology, Innate Immunity
Antigen References

1. Lanier LL. 1997. Immunity 6:371.
2. Yokoyama WM, et al. 1993. Ann. Rev. Immunol. 11:613.
3. Koo GC, et al. 1986. J. Immunol. 137:3742.
4. Giorda R, et al. 1991. J. Immunol. 147:1701.

Gene ID
17059 View all products for this Gene ID
UniProt
View information about NK-1.1 on UniProt.org

Related FAQs

How many biotin molecules are per antibody structure?
We don't routinely measure the number of biotins with our antibody products but the number of biotin molecules range from 3-6 molecules per antibody.

Other Formats

View All NK-1.1 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse NK-1.1 PK136 FC
Biotin anti-mouse NK-1.1 PK136 FC
FITC anti-mouse NK-1.1 PK136 FC
PE anti-mouse NK-1.1 PK136 FC
Purified anti-mouse NK-1.1 PK136 FC,CyTOF®,IP,Depletion,Block,IHC-F
PE/Cyanine7 anti-mouse NK-1.1 PK136 FC
PE/Cyanine5 anti-mouse NK-1.1 PK136 FC
Alexa Fluor® 488 anti-mouse NK-1.1 PK136 FC
Alexa Fluor® 647 anti-mouse NK-1.1 PK136 FC
Pacific Blue™ anti-mouse NK-1.1 PK136 FC
Brilliant Violet 711™ anti-mouse NK-1.1 PK136 FC
APC/Cyanine7 anti-mouse NK-1.1 PK136 FC
PerCP anti-mouse NK-1.1 PK136 FC
PerCP/Cyanine5.5 anti-mouse NK-1.1 PK136 FC
Alexa Fluor® 700 anti-mouse NK-1.1 PK136 FC
Brilliant Violet 421™ anti-mouse NK-1.1 PK136 FC,SB
Brilliant Violet 570™ anti-mouse NK-1.1 PK136 FC
Brilliant Violet 650™ anti-mouse NK-1.1 PK136 FC
Brilliant Violet 510™ anti-mouse NK-1.1 PK136 FC
Brilliant Violet 605™ anti-mouse NK-1.1 PK136 FC
Purified anti-mouse NK-1.1 (Maxpar® Ready) PK136 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse NK-1.1 PK136 FC
Brilliant Violet 785™ anti-mouse NK-1.1 PK136 FC
APC/Fire™ 750 anti-mouse NK-1.1 PK136 FC
TotalSeq™-A0118 anti-mouse NK-1.1 PK136 PG
Ultra-LEAF™ Purified anti-mouse NK-1.1 PK136 FC,CyTOF®,IP,Depletion,Block,IHC-F
TotalSeq™-B0118 anti-mouse NK-1.1 PK136 PG
TotalSeq™-C0118 anti-mouse NK-1.1 PK136 PG
PE/Fire™ 810 anti-mouse NK-1.1 PK136 FC
PE/Fire™ 640 anti-mouse NK-1.1 PK136 FC
Spark UV™ 387 anti-mouse NK-1.1 PK136 FC
PE/Fire™ 700 anti-mouse NK-1.1 PK136 FC
Go To Top Version: 2    Revision Date: 12.08.2016

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account